Mila Lobanova
Directeur Financier/CFO chez Blaze Bioscience, Inc.
Postes actifs de Mila Lobanova
Sociétés | Poste | Début | Fin |
---|---|---|---|
Blaze Bioscience, Inc.
Blaze Bioscience, Inc. Medical/Nursing ServicesHealth Services Blaze Bioscience, Inc. develops tumor paint products and Optide-based guided therapeutics for cancer patients. The firm provides BLZ-100. The company was founded by James M. Olson in 2010 and is headquartered in Seattle, WA. | Directeur des opérations | - | - |
Directeur Financier/CFO | - | - |
Historique de carrière de Mila Lobanova
Anciens postes connus de Mila Lobanova
Sociétés | Poste | Début | Fin |
---|---|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Directeur Financier/CFO | - | - |
Formation de Mila Lobanova
University of Washington | Masters Business Admin |
Moscow Engineering Physics Institute | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Russie | 2 |
Opérationnelle
Director of Finance/CFO | 2 |
Undergraduate Degree | 2 |
Chief Operating Officer | 1 |
Sectorielle
Consumer Services | 3 |
Health Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Blaze Bioscience, Inc.
Blaze Bioscience, Inc. Medical/Nursing ServicesHealth Services Blaze Bioscience, Inc. develops tumor paint products and Optide-based guided therapeutics for cancer patients. The firm provides BLZ-100. The company was founded by James M. Olson in 2010 and is headquartered in Seattle, WA. | Health Services |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Mila Lobanova
- Expérience